Name
AS TFTAK
Registry code
11930972
VAT number
EE101379478
Type
AS - Joint Stock Company
Status
Registered
Foundation date
23.04.2010 (14)
Financial year
01.01-31.12
Capital
39 375.00 €
Activity
72111 - Research and experimental development on biotechnology
2 466 976 €
231 523 €
9%
2 443 €
(estimate is approximate)
2 085 195 €
84
Submitted
No tax arrears
11%
6%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Bioexpert 10075074 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| AS Laser Diagnostic Instruments 10390775 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| AKTSIASELTS SALUTAGUSE PÄRMITEHAS 10423925 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| AS PRFoods 11560713 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| Tallinna Tehnikaülikool 74000323 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| Martin Lall 03.11.1964 (60) | - | Board member | - | |
| Aavo Sõrmus 10.12.1972 (51) | - | - | Indirect ownership | Chairman of the board |
| Raivo Vilu 24.01.1945 (79) | - | - | Indirect ownership | |
| Kaja Kuivjõgi 13.08.1967 (57) | - | - | - | Board member |
| David Ashley Clark 19.03.1988 (36) | - | - | - | Board member |
| Ildar Nisamedtinov 07.10.1976 (48) | - | - | - | Board member |
| Kuldar Leis 29.05.1968 (56) | - | - | - | Board member |
| 2019 16.06.2020 | 2020 02.06.2021 | 2021 30.06.2022 | 2022 21.06.2023 | 2023 20.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 1 724 767 € | 2 404 350 € | 2 532 333 € | 2 886 219 € | 2 466 976 € |
| Net profit (loss) for the period | 82 596 € | 352 370 € | 372 234 € | 390 860 € | 231 523 € |
| Profit Margin | 5% | 15% | 15% | 14% | 9% |
| Current Assets | 980 588 € | 1 250 649 € | 1 337 482 € | 1 673 480 € | 1 438 325 € |
| Fixed Assets | 809 170 € | 868 059 € | 1 190 280 € | 1 974 715 € | 2 231 855 € |
| Total Assets | 1 789 758 € | 2 118 708 € | 2 527 762 € | 3 648 195 € | 3 670 180 € |
| Current Liabilities | 680 911 € | 752 028 € | 701 502 € | 920 079 € | 755 662 € |
| Non Current Liabilities | 370 639 € | 276 102 € | 363 448 € | 874 444 € | 829 323 € |
| Total Liabilities | 1 051 550 € | 1 028 130 € | 1 064 950 € | 1 794 523 € | 1 584 985 € |
| Share Capital | 39 375 € | 39 375 € | 39 375 € | 39 375 € | 39 375 € |
| Equity | 738 208 € | 1 090 578 € | 1 462 812 € | 1 853 672 € | 2 085 195 € |
| Employees | 59 | 68 | 80 | 94 | 84 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 992 582.3 € | 309 344.76 € | 330 836.51 € | 82 |
| 2023 Q4 | 669 877.64 € | 325 857.85 € | 335 862.46 € | 87 |
| 2023 Q3 | 624 873.38 € | 338 560.87 € | 343 521.25 € | 87 |
| 2023 Q2 | 856 227.37 € | 310 357.09 € | 319 636.16 € | 98 |
| 2023 Q1 | 1 069 992.28 € | 334 110.21 € | 356 325.05 € | 97 |
| 2022 Q4 | 785 267.33 € | 323 432.51 € | 346 096.1 € | 107 |
| 2022 Q3 | 865 803.69 € | 333 051.75 € | 354 656.22 € | 114 |
| 2022 Q2 | 726 218.81 € | 322 539.23 € | 310 337.64 € | 115 |
| 2022 Q1 | 597 915.46 € | 282 425.2 € | 294 600.11 € | 107 |
| 2021 Q4 | 1 001 242.87 € | 281 951.58 € | 274 546.67 € | 99 |
| 2021 Q3 | 916 953.22 € | 245 227.76 € | 261 597.06 € | 93 |
| 2021 Q2 | 537 570.79 € | 225 554.58 € | 242 137.18 € | 92 |
| 2021 Q1 | 808 388.3 € | 245 393.44 € | 239 783.61 € | 92 |
| 2020 Q4 | 549 704.05 € | 220 598.16 € | 225 888.19 € | 90 |
| 2020 Q3 | 1 026 958 € | 219 726.11 € | 235 525.27 € | 83 |
| 2020 Q2 | 454 296.32 € | 195 411.15 € | 203 970.38 € | 84 |
| 2020 Q1 | 548 081.54 € | 203 119.15 € | 199 031.75 € | 77 |
